Home › Appendiceal Cancer › NCT05734430
Genetics of Appendix Cancer Study
RecruitingObservational studyHealthy volunteers welcome
Genetics of Appendix Cancer: The GAP Study
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: GAP Social * Known diagnosis of appendix cancer in the United States * Mentally and physically able to consent and participate in the study GAP Vanderbilt * Known diagnosis of appendix cancer * Diagnosed by and/or consulting with a physician/clinical provider participating in the GAP Study * Mentally and physically able to consent and participate in the study GAP Parent * Biological parents (mother and/or father) of individuals actively participating in the GAP Study * Residing in the United States * Mentally and physically able to consent and participate in the study Exclusion Criteria: * Women pregnant at the time of consent * Prisoners * Unable to provide informed consent * Unable to read, write, or complete questionnaires in English
About the study
The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal cancer who are ages 18+ years.
What is being tested
- Genetic profiling (genetic)
- Retrospective tissue procurement (other)
Sponsor: Andreana Holowatyj, PhD, MSCI · Participants: 700 · Started: Nov 11, 2022
Contact the study team
- GAP Study Coordinator (Rebecca B.) · Phone: 615-936-8544
Official record on ClinicalTrials.gov — NCT05734430
Locations in the U.S.
| Tennessee | Vanderbilt-Ingram Cancer Center, Nashville |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.